Matrix metalloproteinases (MMPs) in oral diseases.

Matrix metalloproteinases (MMPs) are a group of enzymes that in concert are responsible for the degradation of most extracellular matrix proteins during organogenesis, growth and normal tissue turnover. The expression and activity of MMPs in adult tissues is normally quite low, but increases significantly in various pathological conditions that may lead into unwanted tissue destruction, such as inflammatory diseases, tumour growth and metastasis. MMPs have a marked role also in tissue destructive oral diseases. The role of collagenases, especially MMP-8, in periodontitis and peri-implantitis is the best-known example of the unwanted tissue destruction related to increased presence and activity of MMPs at the site of disease, but evidence has been brought forward to indicate that MMPs may be involved also in other oral diseases, such as dental caries and oral cancer. This brief review describes some of the history, the current status and the future aspects of the work mainly of our research groups looking at the presence and activity of various MMPs in different oral diseases, as well as some of the MMP-related aspects that may facilitate the development of new means of diagnosis and treatment of oral diseases.

[1]  B. Eley,et al.  Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels , 1998, British Dental Journal.

[2]  T. Salo,et al.  The Expression of MMP-8 in Human Odontoblasts and Dental Pulp Cells is Down-regulated by TGF-β1 , 2000, Journal of dental research.

[3]  T. Salo,et al.  Regulation and Interactions of MT1-MMP and MMP-20 in Human Odontoblasts and Pulp Tissue in vitro , 2002, Journal of dental research.

[4]  T. Salo,et al.  Expression and Regulation of MMP-20 in Human Tongue Carcinoma Cells , 2001, Journal of dental research.

[5]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[6]  T. Salo,et al.  Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. , 2003, European journal of oral sciences.

[7]  N. Fedarko,et al.  Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Y. Konttinen,et al.  Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. , 1996, Journal of clinical periodontology.

[9]  Hidehiko Sano,et al.  Degradation patterns of different adhesives and bonding procedures. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  T. Salo,et al.  Cellular source, activation and inhibition of dental plaque collagenase. , 1995, Journal of clinical periodontology.

[11]  T. Salo,et al.  Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. , 2002, Journal of clinical periodontology.

[12]  T. Sorsa,et al.  A trypsin-like protease from Bacteroides gingivalis: partial purification and characterization. , 1987, Journal of periodontal research.

[13]  H. Fullmer,et al.  Collagenolytic Activity in Gingivae of Man , 1966, Nature.

[14]  M. Hidalgo,et al.  Development of matrix metalloproteinase inhibitors in cancer therapy. , 2001, Journal of the National Cancer Institute.

[15]  T. Salo,et al.  Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid. , 2003, Clinical oral implants research.

[16]  T. Salo,et al.  Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells , 1997, The Journal of Biological Chemistry.

[17]  D. Scadden,et al.  Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Speight,et al.  Matrix metalloproteinases and oral cancer. , 1999, Oral oncology.

[19]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[20]  U. Stenman,et al.  Immunochemical demonstration of an ovarian cancer‐associated urinary peptide , 1982, International journal of cancer.

[21]  C. Lapière,et al.  Collagenolytic activity in amphibian tissues: a tissue culture assay. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Ristimäki,et al.  Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. , 1991, Cancer research.

[23]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[24]  J. Tagami,et al.  Long-term Durability of Dentin Bonds Made with a Self-etching Primer, in vivo , 1999, Journal of dental research.

[25]  M. Larmas,et al.  A Novel Organ Culture Method to Study the Function of Human Odontoblasts in vitro: Gelatinase Expression by Odontoblasts is Differentially Regulated by TGF-β1 , 1998, Journal of dental research.

[26]  H. Larjava,et al.  Expression of matrix metalloproteinase-2 and -9 during early human wound healing. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[27]  H. Larjava,et al.  The Activation and Function of Host Matrix Metalloproteinases in Dentin Matrix Breakdown in Caries Lesions , 1998, Journal of dental research.

[28]  J. Gunsolley,et al.  Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. , 2003, Annals of periodontology.

[29]  C. Overall,et al.  The matrix metalloproteinase gelatinase A in human dentine. , 2000, Archives of oral biology.

[30]  T. Sorsa,et al.  The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. , 2004, Journal of periodontology.

[31]  T. Salo,et al.  Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. , 2003, Journal of periodontal research.

[32]  T. Salo,et al.  Airway Obstruction Correlates with Collagenase-2 (MMP-8) Expression and Activation in Bronchial Asthma , 2002, Laboratory Investigation.

[33]  T. Salo,et al.  Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. , 2003, Journal of periodontal research.

[34]  T. Sorsa,et al.  Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. , 1988, Journal of periodontal research.

[35]  Antti-Pekka Sarin,et al.  MMP-9 Activation by Tumor Trypsin-2 Enhances in vivo Invasion of Human Tongue Carcinoma Cells , 2002, Journal of dental research.

[36]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[37]  T. Salo,et al.  Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates. , 2002, International endodontic journal.

[38]  T. Salo,et al.  The Effects of MMP Inhibitors on Human Salivary MMP Activity and Caries Progression in Rats , 2001, Journal of dental research.

[39]  T. Salo,et al.  Human Odontoblast Culture Method: The Expression of Collagen and Matrix Metalloproteinases (MMPs) , 2001, Advances in dental research.

[40]  T. Salo,et al.  Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. , 2003, Biochemistry.

[41]  F. Tay,et al.  Mechanical stability of resin-dentin bond components. , 2005, Dental materials : official publication of the Academy of Dental Materials.

[42]  U. Bergmann,et al.  Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2* , 1997, The Journal of Biological Chemistry.

[43]  L. Liotta,et al.  Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis , 1982, International journal of cancer.

[44]  B. Marmer,et al.  Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact Propeptide* , 2002, The Journal of Biological Chemistry.

[45]  T. Salo,et al.  Scientific Basis of a Matrix Metalloproteinase‐8 Specific Chair‐side Test for Monitoring Periodontal and Peri‐implant Health and Disease , 1999, Annals of the New York Academy of Sciences.

[46]  T. Salo,et al.  Expression and induction of collagenases (MMP‐8 and ‐13) in plasma cells associated with bone‐destructive lesions , 2001, The Journal of pathology.

[47]  S. Goodison,et al.  Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. , 2003, Differentiation; research in biological diversity.

[48]  T. Salo,et al.  The Localization of Matrix Metalloproteinase-20 (MMP-20, Enamelysin) in Mature Human Teeth , 2002, Journal of dental research.

[49]  T. Salo,et al.  Endostatin Inhibits Human Tongue Carcinoma Cell Invasion and Intravasation and Blocks the Activation of Matrix Metalloprotease-2, -9, and -13* , 2003, Journal of Biological Chemistry.

[50]  T. Salo,et al.  The in vivo Expression of the Collagenolytic Matrix Metalloproteinases (MMP-2, -8, -13, and -14) and Matrilysin (MMP-7) in Adult and Localized Juvenile Periodontitis , 2000, Journal of dental research.

[51]  J. Holopainen,et al.  Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy. , 2003, Investigative ophthalmology & visual science.

[52]  U. Stenman.  Tumor-associated trypsin inhibitor. , 2002, Clinical chemistry.

[53]  Hidehiko Sano,et al.  SEM and TEM analysis of water degradation of human dentinal collagen. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[54]  T. Salo,et al.  Expression and regulation of collagenase‐2 (MMP‐8) in head and neck squamous cell carcinomas , 2002, The Journal of pathology.

[55]  Hidehiko Sano,et al.  Micromorphological changes in resin-dentin bonds after 1 year of water storage. , 2002, Journal of biomedical materials research.

[56]  C. López-Otín,et al.  Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.

[57]  H. Nagase.  Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[58]  Pauline M. Rudd,et al.  Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9) , 2002, Critical reviews in biochemistry and molecular biology.

[59]  L. Liotta,et al.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.

[60]  I. Nishimoto,et al.  Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. , 2002, International journal of oncology.

[61]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[62]  C Yiu,et al.  Collagen Degradation by Host-derived Enzymes during Aging , 2004, Journal of dental research.

[63]  P. Kinnunen,et al.  Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro. , 2001, Cancer research.

[64]  Stephen J. Weiss,et al.  Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.

[65]  T. Salo,et al.  Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. , 1985, The Journal of biological chemistry.

[66]  T. Salo,et al.  Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. , 1998, British Journal of Cancer.

[67]  G I Murray,et al.  Matrix metalloproteinases in tumour invasion and metastasis , 1999, The Journal of pathology.

[68]  T. Sorsa,et al.  The in vivo Levels of Matrix Metalloproteinase-1 and -8 in Gingival Crevicular Fluid during Initial Orthodontic Tooth Movement , 2003, Journal of dental research.

[69]  T. Salo,et al.  Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines , 2002, Anti-cancer drugs.